Company: BNBX
Filing Date: 2025-10-30
Form Type: S-1
Source: 0001104659-25-103871
Chunk: 141

Company: BNB PLUS CORP.
Filing Date: 2025-10-30
Form: S-1
Chunk 141
---
. In accordance with the requirements of Item 402(v) of Regulation S-K, the following adjustments were made to Dr. Hayward and Mr. Shorrock’s total compensation for each year to determine the compensation actually paid which is reported above: |

| ​    
 ​    
 ​    
 ​    
 Year | ​ 
 ​ 
 ​ 
 ​ | Reported     
 Summary      
 Compensation 
 Table Total  
 for PEO      |         | ​ 
 ​ 
 ​ 
 ​ | ​         
 Reported  
 Value of  
 Equity    
 Awards(a) |   | ​ 
 ​ 
 ​ 
 ​ | ​              
 ​              
 Equity         
 Award          
 Adjustments(b) |   | ​ 
 ​ 
 ​ 
 ​ | ​                
 ​                
 Compensation     
 Actually Paid to 
 PEO              |         |
|:-----|:--|:-------------|--------:|:--|:----------|:--|:--|:---------------|:--|:--|:-----------------|--------:|
| 2025 | ​ | $            | 400,000 | ​ | $         | — | ​ | $              | — | ​ | $                | 400,000 |
| 2024 | ​ | $            | 387,623 | ​ | $         | — | ​ | $              | — | ​ | $                | 387,623 |

| (a) | The grant date fair market value of equity awards represents the total of the amounts reported in the “Stock Awards” and “Option Awards” columns in the Summary Compensation Table for the applicable year. |

| (b) | There was no equity award adjustment for each of the applicable years shown above, as all equity awards granted were fully vested on the date of grant. |

81

| (c) | The amount reported for 2025 was annualized based on Mr. Shorrock’s current annual base salary per his employment agreement. |

| (3) | The dollar amounts reported in column (d) represent the average of the amounts reported for the Company’s named executive officers as a group (excluding Dr. Hayward, who has served as our Chairman, Chief Executive Officer and President) in the “Total” column of the Summary Compensation Table in each applicable year. The names of each of the named executive officers (excluding Dr. Hayward) included for purposes of calculating the average amounts in each applicable year are as follows: (i) for 2025 and 2024, Beth M. Jantzen, Clay Shorrock (through September